Latest Xueda Education Group (XUE) Headlines China's TAL

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Xueda Education Group (XUE) Headlines

China's TAL Education Gets High Grades For Its Growth
at Investor's Business Daily - Wed Mar 05, 12:57PM CST
China's stagnating population growth may be in for a big boost in the wake of changes to its family planning rules. The Communist Party of China announced a major overhaul of family planning rules late last year. Under the new policy, married couples...

Why Shares of Xueda Education Group Fell
Jeremy Bowman, The Motley Fool - Motley Fool - Mon Mar 03, 4:18PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What:  Shares of  Xueda Education Group  were getting held...

Strayer Education Upped to Strong Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 4:25PM CST
On Feb 25, Zacks Investment Research upgraded Strayer Education to a Zacks Rank #1 (Strong Buy)

Xueda Education Group Reports Fourth Quarter and Full-Year 2013 Financial Results and Declares Annual Cash Dividend of $0.16 per ADS
PR Newswire - Wed Feb 26, 3:05PM CST
Xueda Education Group (NYSE: XUE) ("Xueda" or the "Company"), a leading national provider of personalized tutoring services for primary and secondary school students in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2013.

Strayer Education Q4 Earnings Surpass Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 24, 9:20AM CST
Strayer Education's fourth-quarter 2013 adjusted earnings of $1.32 per share surpassed the Zacks Consensus Estimate.

Xueda Education Group to Report Fourth Quarter and Full-Year 2013 Financial Results
PR Newswire - Fri Feb 14, 5:00AM CST
Xueda Education Group (NYSE: XUE) ("Xueda" or the "Company"), a leading national provider of personalized tutoring services for primary and secondary school students in China, today announced that it will release its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2013, after the U.S. market closes on February 26, 2014.

48% of SAR Professionals Consider Lack of Funding to Be the Biggest Barrier to SAR Development
PR Newswire - Thu Feb 13, 12:00AM CST
The greatest challenge SAR professionals are currently facing is how to ensure that the best life saving standards are practiced while trying to increasingly balance cost against required capability.

The Zacks Analyst Blog Highlights:American Public Education, Apollo Education Group, Strayer Education, Xueda Education Group and Alexion Pharmaceuticals
PR Newswire - Thu Jan 23, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the American Public Education, Inc. (Nasdaq:APEI-Free Report), Apollo Education Group, Inc. (Nasdaq:APOL-Free Report), Strayer Education Inc. (Nasdaq:STRA-Free Report), Xueda Education Group (NYSE:XUE-Free Report) and Alexion Pharmaceuticals, Inc.'s (Nasdaq:ALXN-Free Report).

Xueda Education Group (XUE) Jumps: Stock Rises by 9.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 23, 8:18AM CST
Xueda Education Group (XUE) was a big mover last session, as the company saw its shares rise by over 9% on the day.

American Public Upgraded to Strong Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 22, 11:20AM CST
On Jan 21, Zacks Investment Research upgraded American Public Education to a Zacks Rank #1 (Strong Buy)

Apollo Education Soars on Raised Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 09, 11:20AM CST
Apollo Education Group's share price shot up 14.20% and reached a new 52 week high of $31.94 on Jan 8

APOL Beats Earnings, Revs Weak - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 08, 10:43AM CST
Apollo Education Group's adjusted earnings of $1.04 per share in the first quarter of fiscal 2014 beat the Zacks Consensus Estimate of 90 cents by 15.6%.

EDU Reaches 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 02, 11:30AM CST
Shares of New Oriental Education & Technology Group reached a 52-week high of $32.00 on Monday, Dec 31, 2013,

Apollo Education Upped to Strong Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 31, 5:28PM CST
On Dec 31, Zacks Investment Research upgraded Apollo Education Group to a Zacks Rank #1 (Strong Buy)

Universal Technical Stays Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 27, 11:00AM CST
On Dec 26, we reiterated our Neutral recommendation on Universal Technical Institute

Strayer Education Stays Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 19, 4:00PM CST
On Dec 17, we reiterated our Neutral recommendation on Strayer Education Inc.

Apollo Global Buys Open Colleges - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 18, 3:50PM CST
Apollo Global, Inc., the wholly-owned subsidiary of Apollo Education Group has agreed to acquire 70% of the outstanding stock of Open Colleges Australia Pty Ltd

Universal Technical Hits 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 09, 10:30AM CST
Shares of Universal Technical Institute reached a 52-week high of $15.16 on Friday, Dec 6, 2013.

Capella Education Initiates Dividend - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 06, 10:30AM CST
The board of directors of Capella Education Company initiated a quarterly cash dividend of 35 cents per outstanding share of common stock

Capella Education Down to Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 03, 3:25PM CST
On Nov 18, we reverted our recommendation on Capella Education Company to Neutral from Outperform due to management's cautious fourth-quarter guidance.

Xueda Education Group (XUE) Stock Research Links

XUE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 310

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 386

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 513

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 385

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 518

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
icles